Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
Renal vein thrombosis is the occlusion of one or both renal veins. It may present with either chronic bilateral thrombosis or, less often, with acute unilateral or bilateral thrombosis. It may be associated with other thromboembolism, including pulmonary embolism.
- The overall prevalence is unknown, as renal vein thrombosis is probably underdiagnosed.
- it is rare in children and usually due to severe illness, eg asphyxia, severe infection, dehydration.
Nephrotic syndrome is the most common cause. Other causes include:
- Renal cancer
- Renal transplantation
- Behçet's disease
- Hypercoagulable states
- Antiphospholipid syndrome
Symptoms may be difficult to differentiate from those of the underlying condition, eg nephrotic syndrome or renal malignancy:
- Acute: loin pain, decline in renal function, haematuria, renal enlargement, asymmetrical leg oedema, increased proteinuria in nephrotic syndrome.
- Chronic: there may be no symptoms or signs and it is detected by decline in renal function, increase in proteinuria or by being seen on abdominal MRI scan.
- Other features of both acute and chronic forms are pulmonary emboli, increased peripheral oedema, dilated abdominal veins, left varicocele (if the left renal vein is thrombosed).
It should be considered as a possible cause of:
- Increased proteinuria or decline in renal function in patients with nephrotic syndrome.
- Pulmonary emboli with no lower limb deep vein thrombosis.
- Serum creatinine and urinary protein (unexplained decline in renal function or sudden increase in proteinuria). Other laboratory investigations will depend on the clinical situation, eg for nephrotic syndrome.
- Doppler ultrasound scan.
- Intravenous pyelogram (IVP) findings are rarely specific but may show an enlarged kidney. If the renal pelvis is observed, it is usually distorted. A characteristic but uncommon finding is notching of the ureter, caused by tortuous collateral veins near the ureters.
- Inferior vena cavography can be diagnostic but otherwise will need selective renal vein catheterisation to be performed.
- Renal arteriography may be useful in cases of renal trauma or tumour, when renal artery involvement is common.
- Renal ultrasound is usually not sensitive enough to assist in making the diagnosis.
- CT or MRI scanning is currently the procedure of choice for non-invasive diagnosis. They may also help detect the presence of a tumour.
- Renal biopsy is essential in evaluating patients with nephrotic syndrome.
- Glomerulonephritis (especially if it causes nephrotic syndrome) - most commonly membranous glomerulonephritis, but may also be associated with membranoproliferative, minimal change or rapidly progressive glomerulonephritis. Also systemic lupus erythematosus (SLE) and amyloidosis.
- Renal cell carcinoma - by extrinsic pressure on the renal vein or invasion of the renal vein or inferior vena cava. May also be due to extrinsic compression by any other tumour or retroperitoneal mass.
- Dehydration, especially in infants.
- Hypercoagulable states.
- May be associated with thrombocytopenia.
- Post-renal transplantation.
- Anticoagulation with warfarin. If renal vein thrombosis is associated with pulmonary emboli, anticoagulation should be continued for as long as nephrotic syndrome persists.
- Streptokinase may be used to lyse acute thrombosis.
- Statins, angiotensin-converting enzyme (ACE) inhibitors or angiotensin-II receptor blockers decrease proteinuria from nephrotic syndrome. Decreasing protein loss in the urine decreases hypercoagulability.
- Treatment of any underlying associated disease.
- Surgical treatment is rarely required.
- Inferior vena caval filters may be used in bilateral renal vein thrombosis.
- Surgery may be necessary for renal vein thrombosis caused by renal cell cancer.
- Recurrent thromboembolism, eg pulmonary embolus.
- Acute kidney injury.
- Complications specific to the underlying cause, eg graft failure after renal transplantation.
- Prognosis is determined by the effects on nephrotic syndrome, renal dysfunction or the complications resulting from thromboembolism.
- Prognosis of any underlying cause is worsened by the onset of acute renal vein thrombosis.
- Acute thrombus formation adversely affects graft survival after renal transplantation.
Prophylactic subcutaneous heparin for those with any condition that potentially predisposes to renal vein thrombosis.
Further reading and references
Harris SL, Smith MP, Laurie A, et al; Neonatal renal vein thrombosis and prothrombotic risk. Acta Paediatr. 2010 Jul99(7):1104-7. Epub 2010 Feb 11.
Nickolas TL, Radhakrishnan J, Appel GB; Hyperlipidemia and thrombotic complications in patients with membranous nephropathy. Semin Nephrol. 2003 Jul23(4):406-11.
Bianchi S, Bigazzi R, Caiazza A, et al; A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis. 2003 Mar41(3):565-70.
Janda SP; Bilateral renal vein thrombosis and pulmonary embolism secondary to membranous Indian J Nephrol. 2010 Jul20(3):152-5.